[{"address1": "1185 Avenue of the Americas", "address2": "3rd Floor", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "973 242 0005", "website": "https://www.synaptogen.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. The company was incorporated in 2012 and is headquartered in New York, New York.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Alan J. Tuchman M.D., MBA(FAAN)", "age": 76, "title": "CEO & Director", "yearBorn": 1947, "fiscalYear": 2023, "totalPay": 303347, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel L. Alkon M.D.", "age": 81, "title": "President, Chief Scientific Officer & Director", "yearBorn": 1942, "fiscalYear": 2023, "totalPay": 375000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Weinstein", "age": 63, "title": "CFO, Executive VP, Treasurer & Secretary", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 568918, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 5.61, "open": 5.78, "dayLow": 4.772, "dayHigh": 5.95, "regularMarketPreviousClose": 5.61, "regularMarketOpen": 5.78, "regularMarketDayLow": 4.772, "regularMarketDayHigh": 5.95, "beta": 1.58, "forwardPE": -3.012195, "volume": 248245, "regularMarketVolume": 248245, "averageVolume": 42600, "averageVolume10days": 88761, "averageDailyVolume10Day": 88761, "bid": 4.77, "ask": 5.06, "bidSize": 100, "askSize": 100, "marketCap": 5361530, "fiftyTwoWeekLow": 0.22, "fiftyTwoWeekHigh": 8.775, "fiftyDayAverage": 4.791313, "twoHundredDayAverage": 2.1351056, "currency": "USD", "enterpriseValue": -23501508, "floatShares": 1057517, "sharesOutstanding": 1085330, "sharesShort": 11941, "sharesShortPriorMonth": 21613, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.011, "heldPercentInsiders": 0.024349999, "heldPercentInstitutions": 0.039049998, "shortRatio": 0.67, "shortPercentOfFloat": 0.0111, "bookValue": 25.267, "priceToBook": 0.19551194, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -13779278, "trailingEps": -29.5, "forwardEps": -1.64, "enterpriseToEbitda": 2.829, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "SNPX", "underlyingSymbol": "SNPX", "shortName": "Synaptogenix, Inc.", "longName": "Synaptogenix, Inc.", "firstTradeDateEpochUtc": 1607437800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d14ff140-0ac6-3af9-a386-f918dc6aa47f", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.94, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 30099998, "totalCashPerShare": 27.733, "ebitda": -8307507, "quickRatio": 7.039, "currentRatio": 7.14, "returnOnAssets": -0.14905, "returnOnEquity": -0.19799, "freeCashflow": -427116, "operatingCashflow": -5173209, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-10"}]